TY - JOUR
T1 - Structural Analysis of CYP2R1 in Complex with Vitamin D3
AU - Strushkevich, Natallia
AU - Usanov, Sergey A.
AU - Plotnikov, Alexander N.
AU - Jones, Glenville
AU - Park, Hee Won
N1 - Funding Information:
We thank members of Structural Genomics Consortium, notably Peter Loppnau for his expert technical Assistance, Wolfram Tempel for crystallographic refinement of the structure and Jinrong Min for assistance with X-ray data collection. We also thank Tatiana Pechurskaya and Alexander Baranovsky for their technical support. This work was supported by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust.
PY - 2008/6/27
Y1 - 2008/6/27
N2 - The activation of vitamin D to its hormonal form is mediated by cytochrome P450 enzymes. CYP2R1 catalyzes the initial step converting vitamin D into 25-hydroxyvitamin D. A CYP2R1 gene mutation causes an inherited form of rickets due to 25-hydroxylase deficiency. To understand the narrow substrate specificity of CYP2R1 we obtained the hemeprotein in a highly purified state, confirmed the enzyme as a vitamin D 25-hydroxylase, and solved the crystal structure of CYP2R1 in complex with vitamin D3. The CYP2R1 structure adopts a closed conformation with the substrate access channel being covered by the ordered B′-helix and slightly opened to the surface, which defines the substrate entrance point. The active site is lined by conserved, mostly hydrophobic residues. Vitamin D3 is bound in an elongated conformation with the aliphatic side-chain pointing toward the heme. The structure reveals the secosteroid binding mode in an extended active site and allows rationalization of the molecular basis of the inherited rickets associated with CYP2R1.
AB - The activation of vitamin D to its hormonal form is mediated by cytochrome P450 enzymes. CYP2R1 catalyzes the initial step converting vitamin D into 25-hydroxyvitamin D. A CYP2R1 gene mutation causes an inherited form of rickets due to 25-hydroxylase deficiency. To understand the narrow substrate specificity of CYP2R1 we obtained the hemeprotein in a highly purified state, confirmed the enzyme as a vitamin D 25-hydroxylase, and solved the crystal structure of CYP2R1 in complex with vitamin D3. The CYP2R1 structure adopts a closed conformation with the substrate access channel being covered by the ordered B′-helix and slightly opened to the surface, which defines the substrate entrance point. The active site is lined by conserved, mostly hydrophobic residues. Vitamin D3 is bound in an elongated conformation with the aliphatic side-chain pointing toward the heme. The structure reveals the secosteroid binding mode in an extended active site and allows rationalization of the molecular basis of the inherited rickets associated with CYP2R1.
KW - X-ray crystallography
KW - human cytochrome P450
KW - membrane protein
KW - vitamin D
KW - vitamin D 25-hydroxylase
UR - http://www.scopus.com/inward/record.url?scp=44649195596&partnerID=8YFLogxK
U2 - 10.1016/j.jmb.2008.03.065
DO - 10.1016/j.jmb.2008.03.065
M3 - Article
C2 - 18511070
AN - SCOPUS:44649195596
SN - 0022-2836
VL - 380
SP - 95
EP - 106
JO - Journal of Molecular Biology
JF - Journal of Molecular Biology
IS - 1
ER -